News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,394 Results
Type
Article (47624)
Company Profile (198)
Press Release (570558)
Multimedia
Podcasts (136)
Webinars (21)
Section
Business (172775)
Career Advice (2539)
Deals (31901)
Drug Delivery (128)
Drug Development (76404)
Employer Resources (162)
FDA (16374)
Job Trends (13328)
News (305922)
Policy (32021)
Tag
Academia (2377)
Academic (1)
Accelerated approval (17)
Adcomms (34)
Allergies (107)
Alliances (43478)
ALS (126)
Alzheimer's disease (1589)
Antibody-drug conjugate (ADC) (189)
Approvals (16359)
Artificial intelligence (373)
Autoimmune disease (44)
Automation (19)
Bankruptcy (325)
Best Places to Work (9919)
BIOSECURE Act (22)
Biosimilars (144)
Biotechnology (99)
Bladder cancer (113)
Brain cancer (42)
Breast cancer (398)
Cancer (3214)
Cardiovascular disease (285)
Career advice (2135)
Career pathing (36)
CAR-T (196)
CDC (47)
Cell therapy (545)
Cervical cancer (26)
Clinical research (63482)
Collaboration (1115)
Company closure (4)
Compensation (849)
Complete response letters (49)
COVID-19 (2722)
CRISPR (68)
C-suite (453)
Cystic fibrosis (117)
Data (3466)
Decentralized trials (2)
Denatured (34)
Depression (94)
Diabetes (377)
Diagnostics (5665)
Digital health (23)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (159)
Drug pricing (166)
Drug shortages (35)
Duchenne muscular dystrophy (178)
Earnings (70951)
Editorial (52)
Employer branding (20)
Employer resources (144)
Events (94133)
Executive appointments (862)
FDA (18497)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (950)
Gene editing (145)
Generative AI (28)
Gene therapy (442)
GLP-1 (944)
Government (4176)
Grass and pollen (7)
Guidances (324)
Healthcare (15534)
HIV (44)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (215)
Immuno-oncology (17)
Indications (43)
Infectious disease (2921)
Inflammatory bowel disease (161)
Inflation Reduction Act (11)
Influenza (77)
Intellectual property (151)
Interviews (466)
IPO (15186)
IRA (57)
Job creations (3769)
Job search strategy (1770)
Kidney cancer (14)
Labor market (60)
Layoffs (588)
Leadership (30)
Legal (7747)
Liver cancer (82)
Longevity (12)
Lung cancer (475)
Lymphoma (238)
Machine learning (20)
Management (54)
Manufacturing (510)
MASH (112)
Medical device (11625)
Medtech (11638)
Mergers & acquisitions (17508)
Metabolic disorders (1005)
Multiple sclerosis (105)
NASH (23)
Neurodegenerative disease (164)
Neuropsychiatric disorders (48)
Neuroscience (2413)
NextGen: Class of 2025 (5284)
Non-profit (3337)
Now hiring (30)
Obesity (521)
Opinion (271)
Ovarian cancer (100)
Pain (142)
Pancreatic cancer (136)
Parkinson's disease (205)
Partnered (21)
Patents (363)
Patient recruitment (245)
Peanut (50)
People (51820)
Pharmaceutical (81)
Pharmacy benefit managers (25)
Phase I (19052)
Phase II (27642)
Phase III (21898)
Pipeline (2352)
Policy (274)
Postmarket research (2553)
Preclinical (7920)
Press Release (48)
Prostate cancer (165)
Psychedelics (47)
Radiopharmaceuticals (243)
Rare diseases (564)
Real estate (5227)
Recruiting (65)
Regulatory (23228)
Reports (39)
Research institute (2201)
Resumes & cover letters (417)
Rett syndrome (11)
RNA editing (13)
RSV (59)
Schizophrenia (117)
Series A (164)
Series B (120)
Service/supplier (10)
Sickle cell disease (72)
Special edition (22)
Spinal muscular atrophy (152)
Sponsored (39)
Startups (3264)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (82)
The Weekly (100)
Vaccines (964)
Venture capital (62)
Weight loss (363)
Women's health (44)
Worklife (21)
Date
Today (105)
Last 7 days (407)
Last 30 days (2123)
Last 365 days (30224)
2025 (21081)
2024 (33288)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39201)
2018 (29904)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (767)
Alabama (59)
Alaska (7)
Arizona (207)
Arkansas (11)
Asia (37960)
Australia (6193)
California (8090)
Canada (2270)
China (738)
Colorado (339)
Connecticut (376)
Delaware (224)
Europe (86939)
Florida (1232)
Georgia (257)
Hawaii (3)
Idaho (41)
Illinois (613)
India (41)
Indiana (344)
Iowa (18)
Japan (251)
Kansas (100)
Kentucky (29)
Louisiana (13)
Maine (67)
Maryland (1096)
Massachusetts (6008)
Michigan (225)
Minnesota (443)
Mississippi (3)
Missouri (88)
Montana (17)
Nebraska (22)
Nevada (90)
New Hampshire (59)
New Jersey (2258)
New Mexico (16)
New York (2158)
North Carolina (1172)
North Dakota (7)
Northern California (3692)
Ohio (219)
Oklahoma (12)
Oregon (31)
Pennsylvania (1657)
Puerto Rico (11)
Rhode Island (28)
South America (1139)
South Carolina (42)
South Dakota (1)
Southern California (3121)
Tennessee (126)
Texas (1198)
United States (29263)
Utah (210)
Virginia (207)
Washington D.C. (73)
Washington State (657)
West Virginia (4)
Wisconsin (76)
618,394 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
Podcast
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out after reportedly sparring with other agency officials over communications strategy; Eli Lilly’s first Phase III readout for oral obesity drug orforglipron missed analyst expectations; and Arrowhead Pharmaceuticals addresses the recent woes of its of partner Sarepta.
August 13, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Hengdian Group’s Apeloa Pharmaceutical uses Flow Chemistry for sustainable manufacturing
August 27, 2025
·
3 min read
Press Releases
Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series
July 16, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
July 16, 2025
·
10 min read
Press Releases
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
August 13, 2025
·
3 min read
Press Releases
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.
August 13, 2025
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance
Agreement covers contract development and manufacturing of lead compound PH-762
July 25, 2025
·
4 min read
1 of 61,840
Next
